Candida vaccines development from point view of US patent application

Human Vaccines

Volumn 7, Issue 11, 2011, Pages 1165-1171

  Wang, Shyh Jen ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Assignee; Candida; Patent analysis; Patent citation; Patent classification; Vaccines

Indexed keywords

FUNGUS VACCINE; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

CANDIDIASIS; DRUG LEGISLATION; HEALTH CARE COST; HUMAN; INFECTION PREVENTION; INFECTION RATE; NONHUMAN; NOTE; PASSIVE IMMUNIZATION; PATENT; SYSTEMIC MYCOSIS; UNITED STATES; VACCINE PRODUCTION;

EID: 81855224534     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.7.11.17821     Document Type: Note

References (23)

1. Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis and treatment. Med Mycol 2007; 45:321-46; PMID:17510856; DOI:10.1080/13693780701218689.
2. Spellberg B. The last vaccine frintier. Scientist 2011; 1.
3. Wilson L, Reyes C, Stolpman M, Speckman J, Allen K, Beney J. The direct cost and incidence of systemic fungal infections. Value Health 2002; 5:26-34; PMID:11873380; DOI:10.1046/j.1524-4733.2002.51108.x.
4. Hong S. The Magic of Patent Information; http://www.wipo.int/sme/en/ documents/patent-information.htm
5. Schwartz HF. Patent Law and Practice. The Bureau of National Affairs, Inc. 2006.
6. Chandrasekharan S, Kumar S, Valley CM, Rai A. Propriety science, open science and the role of patent disclosure: the case of zinc-finger proteins. Nat Biotechnol 2009; 27:140-4; PMID:19204690; DOI:10.1038/nbt0209-140.
7. Poltorak AL, Lerner PJ. Essentials of Intellectual property. John Wiley & Sons, Inc. 2002.
8. Zheng J, Zhao Z, Zhang X, Chen DZ, Huang MH, Lei XP, et al. Industry evolution and key technologies in China based on patent analysis. Scientometrics 2010.
9. Kutlaca -G. Patent-related activities in Serbia from 1921 to 1995. Scientormetrics 1998; 42:171-93; DOI:10.1007/BF02458354.
10. Meyer M, Debackere K, Gla®nzel W. Can applied science be 'good science'? Exploring the relationship between patent citations and citation impact in nanoscience. Scientometrics 2010; 85:527-39; DOI:10.1007/s11192-009- 0154-3.
11. Cassone A. Fungal vaccines: real progress from real challenges. Lancet Infect Dis 2008; 8:114-24; PMID:18222162; DOI:10.1016/S1473-3099(08)70016-1.
12. Levy R, Segal E, Eylan E. Protective immunity against murine candidiasis elicited by Candida albicans ribosomal fractions. Infect Immun 1981; 31:874-8; PMID:7014464.
13. Cárdenas-Freytag L, Cheng E, Mayeux P, Domer JE, Clements JD. Effectiveness of a Vaccine Composed of Heat-Killed Candida albicans and a Novel Mucosal Adjuvant, LT(R192G), against Systemic Candidiasis. Infect Immun 1999; 67:826-33; PMID:9916097.
14. Cole GT, Xue J, Okeke C, Tarcha E, Basrur V, Schaller R, et al. A vaccine against coccidioidomycosis is justified and attainable. Med Mycol 2004; 42:189-216; PMID:15283234; DOI:10.1080/13693 780410001687349.
15. Wang SJ. The stem cell patent landscape as relevant to cancer vaccines. Hum Vaccin 2011; 7:1-4.
16. Lundin P. Is silence still golden? Mapping the RNAi patent landscape. Nat Biotechnol 2011; 29:493-7; PMID:21654666; DOI:10.1038/nbt.1885.
17. Wang SJ. The obviousness rejection as a barrier to vaccine patent prosecution. Hum Vaccin 2011; 7:474-6; PMID:21808149; DOI:10.4161/hv.7.4.14134.
18. Brandenberger A, Stuart H. Value-based strategy. J Econ Manage Strategy 1996; 5:5-24; DOI:10.1111/j.1430-9134.1996.00005.x.
19. Bergman K, Graffm GD. The global stem cell patent landscape: implications fro efficient technology transfer and commercial development. Nat Biotechnol 2007; 25:419-24; PMID:17420745; DOI:10.1038/nbt0407-419.
20. Acosta M, Coronado D, Fernández A. Exploring the quality of environmental technology in Europe: evidence from patent citations. Scientometrics 2009; 80:131-52; DOI:10.1007/s11192-008-2057-0.
21. Wang SJ. Factors to evaluate a patent in addition to citations. Scientometrics 2007; 71:509-22; DOI:10.1007/s11192-007-1698-8.
22. Smith VM. Who's who in additives - a technological approach. Chem Week 1993; 38:137-42.
23. Chakrabarti AK. Competition in high technology: analysis of problems of US, Japan UK, France, West Germany and Canada. IEEE Transition of Engineering Magazine 1991; 38:78-84; DOI:10.1109/17.65763.